Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease

Osteoarthritis and Cartilage

Volumn 17, Issue 8, 2009, Pages 1040-1048

  Scanzello, C R ^a   Umoh, E ^b   Pessler, F ^c   Diaz Torne, C ^d   Miles, T ^e   DiCarlo, E ^b   Potter, H G ^b   Mandl, L ^b   Marx, R ^f   Rodeo, S ^f   Goldring, S R ^b   Crow, M K ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Hospital for Special Surgery   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Inflammation; Interleukin 15; Osteoarthritis; Synovitis; Synovium

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 21; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARTILAGE DEGENERATION; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; KNEE MENISCUS RUPTURE; KNEE OSTEOARTHRITIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIAL FLUID LEVEL; SYNOVIOCYTE; TOTAL KNEE REPLACEMENT;

AGED; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CYTOKINES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-15; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 67650407428     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2009.02.011     Document Type: Article

References (52)

1. Pessler F., Chen L., Dai L., Gomez C., Diaz-Torne C., Paessler M., et al. A histomorphometric analysis of synovial biopsies from individuals with Gulf War Veteran's illness and joint pain compared to normal and osteoarthritis synovium. Clin Rheumatol 27 (2008) 1127-1134
2. Hill C.L., Hunter D.J., Niu J., Clancy M., Guermazi A., Genant H., et al. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis 66 (2007) 1599-1603
3. Ayral X., Pickering E.H., Woodworth T.G., Mackillop N., and Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis - results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 13 (2005) 361-367
4. Goldenberg D.L., Egan M.S., and Cohen A.S. Inflammatory synovitis in degenerative joint disease. J Rheumatol 9 (1982) 204-209
5. Oehler S., Neureiter D., Meyer-Scholten C., and Aigner T. Subtyping of osteoarthritic synoviopathy. Clin Exp Rheumatol 20 (2002) 633-640
6. Pearle A.D., Scanzello C.R., George S., Mandl L.A., DiCarlo E.F., Peterson M., et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 15 (2007) 516-523
7. Benito M.J., Veale D.J., FitzGerald O., van den Berg W.B., and Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 64 (2005) 1263-1267
8. Elliott M.J., Maini R.N., Feldmann M., Long-Fox A., Charles P., Katsikis P., et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36 (1993) 1681-1690
9. McInnes I.B., and Liew F.Y. Cytokine networks-towards new therapies for rheumatoid arthritis. Nat Clin Pract Rheumatol 1 (2005) 31-39
10. Nishimoto N., Yoshizaki K., Miyasaka N., Yamamoto K., Kawai S., Takeuchi T., et al. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 50 (2004) 1761-1769
11. Baslund B., Tvede N., Danneskiold-Samsoe B., Larsson P., Panayi G., Petersen J., et al. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum 52 (2005) 2686-2692
12. Mimori T. Clinical significance of anti-CCP antibodies in rheumatoid arthritis. Intern Med 44 (2005) 1122-1126
13. Lemm G., and Warnatz H. Evidence for enhanced interleukin 2 (IL-2) secretion and IL-2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis. Clin Exp Immunol 64 (1986) 71-79
14. Weyand C.M., Hicok K.C., Conn D.L., and Goronzy J.J. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117 (1992) 801-806
15. Krenn V., Morawietz L., Burmester G.R., Kinne R.W., Mueller-Ladner U., Muller B., et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 49 (2006) 358-364
16. Partsch G., Steiner G., Leeb B.F., Dunky A., Broll H., and Smolen J.S. Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid. J Rheumatol 24 (1997) 518-523
17. Sakkas L.I., Scanzello C., Johanson N., Burkholder J., Mitra A., Salgame P., et al. T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol 5 (1998) 430-437
18. Moos V., Menard J., Sieper J., Sparmann M., and Muller B. Association of HLA-DRB1*02 with osteoarthritis in a cohort of 106 patients. Rheumatology (Oxford) 41 (2002) 666-669
19. Wakitani S., Imoto K., Mazuka T., Kim S., Murata N., and Yoneda M. Japanese generalised osteoarthritis was associated with HLA class I-a study of HLA-A, B, Cw, DQ, DR in 72 patients. Clin Rheumatol 20 (2001) 417-419
20. Englund M., Roos E.M., and Lohmander L.S. Impact of type of meniscal tear on radiographic and symptomatic knee osteoarthritis: a sixteen-year followup of meniscectomy with matched controls. Arthritis Rheum 48 (2003) 2178-2187
21. Hunter D.J., Zhang Y.Q., Niu J.B., Tu X., Amin S., Clancy M., et al. The association of meniscal pathologic changes with cartilage loss in symptomatic knee osteoarthritis. Arthritis Rheum 54 (2006) 795-801
22. Roos E.M. Joint injury causes knee osteoarthritis in young adults. Curr Opin Rheumatol 17 (2005) 195-200
23. Potter H.G., Linklater J.M., Allen A.A., Hannafin J.A., and Haas S.B. Magnetic resonance imaging of articular cartilage in the knee. An evaluation with use of fast-spin-echo imaging. J Bone Joint Surg Am 80 (1998) 1276-1284
24. Verheijen J.H., Nieuwenbroek N.M., Beekman B., Hanemaaijer R., Verspaget H.W., Ronday H.K., et al. Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase. Biochem J 323 (1997) 603-609
25. Shah M.H., Hackshaw K.V., and Caligiuri M.A. A role for IL-15 in rheumatoid arthritis?. Nat Med 4 (1998) 643
26. Kammula U.S., Lee K.H., Riker A.I., Wang E., Ohnmacht G.A., Rosenberg S.A., et al. Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens. J Immunol 163 12 (1999) 6867-6875
27. McInnes I.B., al-Mughales J., Field M., Leung B.P., Huang F.P., Dixon R., et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 2 (1996) 175-182
28. Duitman E.H., Orinska Z., Bulanova E., Paus R., and Bulfone-Paus S. How a cytokine is chaperoned through the secretory pathway by complexing with its own receptor: lessons from interleukin-15 (IL-15)/IL-15 receptor alpha. Mol Cell Biol 28 (2008) 4851-4861
29. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the American rheumatism association. Arthritis Rheum 29 (1986) 1039-1049
30. Hunter D.J., Zhang Y., Niu J., Goggins J., Amin S., LaValley M.P., et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum 54 (2006) 1529-1535
31. Berthiaume M.J., Raynauld J.P., Martel-Pelletier J., Labonte F., Beaudoin G., Bloch D.A., et al. Meniscal tear and extrusion are associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Ann Rheum Dis 64 (2005) 556-563
32. Ding C., Martel-Pelletier J., Pelletier J.P., Abram F., Raynauld J.P., Cicuttini F., et al. Knee meniscal extrusion in a largely non-osteoarthritic cohort: association with greater loss of cartilage volume. Arthritis Res Ther 9 (2007) R21
33. Ling S.M., Patel D.D., Garnero P., Zhan M., Vaduganathan M., Muller D., et al. Serum protein signatures detect early radiographic osteoarthritis. Osteoarthritis Cartilage 17 (2009) 43-48
34. Jung Y.O., Cho M.L., Kang C.M., Jhun J.Y., Park J.S., Oh H.J., et al. Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts. Immunol Lett 109 (2007) 21-27
35. Waldmann T.A., Dubois S., and Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14 (2001) 105-110
36. Kobayashi H., Dubois S., Sato N., Sabzevari H., Sakai Y., Waldmann T.A., et al. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood 105 (2005) 721-727
37. Klebanoff C.A., Finkelstein S.E., Surman D.R., Lichtman M.K., Gattinoni L., Theoret M.R., et al. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+T cells. Proc Natl Acad Sci U S A 101 (2004) 1969-1974
38. Judge A.D., Zhang X., Fujii H., Surh C.D., and Sprent J. Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells. J Exp Med 196 (2002) 935-946
39. Lin C.Y., Chuang T.F., Liao K.W., Huang Y.J., Pai C.C., and Chu R.M. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity. Cancer Lett 272 (2008) 285-295
40. Miranda-Carus M.E., Balsa A., Benito-Miguel M., Perez de Ayala C., and Martin-Mola E. IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate. J Immunol 173 (2004) 1463-1476
41. Ajuwon K.M., Jacobi S.K., Kuske J.L., and Spurlock M.E. Interleukin-6 and interleukin-15 are selectively regulated by lipopolysaccharide and interferon-gamma in primary pig adipocytes. Am J Physiol Regul Integr Comp Physiol 286 (2004) R547-R553
42. Constantinescu C.S., Grygar C., Kappos L., and Leppert D. Interleukin 15 stimulates production of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by human peripheral blood mononuclear cells. Cytokine 13 (2001) 244-247
43. Zygmunt M., Hahn D., Kiesenbauer N., Munstedt K., and Lang U. Invasion of cytotrophoblastic (JEG-3) cells is up-regulated by interleukin-15 in vitro. Am J Reprod Immunol 40 (1998) 326-331
44. Okada Y., Shinmei M., Tanaka O., Naka K., Kimura A., Nakamishi I., et al. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 66 (1992) 680-690
45. Wimsey S., Lien C.F., Sharma S., Brennan P.A., Roach H.I., Harper G.D., et al. Changes in immunolocalisation of beta-dystroglycan and specific degradative enzymes in the osteoarthritic synovium. Osteoarthritis Cartilage 14 (2006) 1181-1188
46. Klimiuk P.A., Sierakowski S., Latosiewicz R., Cylwik B., Skowronski J., and Chwiecko J. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis. Rheumatology (Oxford) 41 (2002) 78-87
47. Lohmander L.S., Brandt K.D., Mazzuca S.A., Katz B.P., Larsson S., Struglics A., et al. Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis. Arthritis Rheum 52 (2005) 3160-3167
48. Wu B., Crampton S.P., and Hughes C.C. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26 (2007) 227-239
49. Burger D., Rezzonico R., Li J.M., Modoux C., Pierce R.A., Welgus H.G., et al. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. Arthritis Rheum 41 (1998) 1748-1759
50. Wakisaka S., Suzuki N., Nagafuchi H., Takeba Y., Kaneko A., Asai T., et al. Characterization of tissue outgrowth developed in vitro in patients with rheumatoid arthritis: involvement of T cells in the development of tissue outgrowth. Int Arch Allergy Immunol 121 (2000) 68-79
51. Jones B.W., Means T.K., Heldwein K.A., Keen M.A., Hill P.J., Belisle J.T., et al. Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol 69 (2001) 1036-1044
52. Spolski R., and Leonard W.J. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 26 (2008) 57-79